Company news
Edesa Biotech, Inc. news in 2023
Edesa Biotech, Inc.'s news releases, calls and decks from 2023, newest first.
Edesa Biotech Reports Fiscal Year 2023 Results
December 14, 2023
Edesa Biotech Reports Final Phase 2b Results for Dermatitis Study
November 19, 2023
Edesa Biotech Secures $10 Million Credit Facility with Company Founder
October 11, 2023
Edesa Biotech Announces One-for-Seven Reverse Share Split
October 9, 2023
Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate
September 27, 2023
Edesa Biotech Reports Fiscal Third Quarter 2023 Results
August 8, 2023
Edesa Biotech's ARDS Drug Inhibits Inflammation from Influenza and Other Pathogens
June 27, 2023
Edesa Biotech Appoints Biotech Deal Veteran to CFO Role
June 26, 2023
Edesa Biotech Reports Fiscal 2nd Quarter 2023 Results
May 10, 2023
Edesa Biotech and FDA Agree on Primary Endpoint for Phase 3 ARDS Drug Study
March 14, 2023
Edesa Biotech Reports Fiscal 1st Quarter 2023 Results
February 9, 2023
Edesa Biotech Receives Regulatory Approval for Phase 2 Vitiligo Study
January 31, 2023
Edesa Biotech Reports Topline Phase 2b Results for Dermatology Drug
January 16, 2023